ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · NUTX

Atlas market file · Equity · United States

Nutex Health Inc.NUTX

Last close
162.07
Change
+6.67%
96-bar range
85.39 – 204.00
As of
7 Aug 2026

Nutex Health Inc. is a services-business services, nec issuer listed as NUTX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:NUTX

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

207.56176.13144.69113.2681.831723 Mar01 Jun07 Aug

up candle   down candle

Latest close162.07
Day change+6.67%
Window high204.00
Window low85.39
96-bar change+70.64%
SnapshotDaily · 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 104 weekly closes (+649.28% over the window).

203.6112.418819 Aug07 Aug

Source rail: Yahoo Finance chart API (NUTX). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for NUTX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

NUTX public profile

Company

Services-business services, nec issuer. Nutex Health Inc. is connected to current market context, cited company sources and its retained research file.

Market

Nutex Health Inc. trades as NUTX on NASDAQ. Nutex Health Inc. (NUTX) has a latest verified close of 162.07, up 6.67%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files NUTX under USA Stocks and Healthcare & Medicine Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Nutex Health wants you to know it's a 'technology-enabled healthcare services company' with a Hospital Division and a Population Health Management Division, which sounds like it could be the plot of a hospital-themed Netflix series. The reality is a lot less glamorous: a 10-Q filed on 30 April 2026 shows $216.5 million in revenue, $46.8 million in net income, and $207.3 million in cash, all for the quarter ending 31 March 2026. That's not 'tech-enabled'-that's a bricks-and-mortar business with a spreadsheet and some ambition. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1479681/000162828026028849/nutx-20260331.htm)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Nutex Health Inc. today

Open full report
NUTX daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Nutex Health Inc. is a healthcare services company with two divisions: a Hospital Division and a Population Health Management Division. The company owns, develops, and operates micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs) across the United States, aiming to make concierge-level care more accessible. Its website is a parade of circles and smiling stock images, but the filings tell a different story. (source: Home - Nutex Health, https://nutexhealth.com/)

The latest 10-Q filed on 30 April 2026 shows the company collected $216.5 million in revenue for the quarter ended 31 March 2026, with net income attributable to the parent of $46.8 million. Operating income clocked in at $81.3 million, and the company ended the period with $207.3 million in cash and cash equivalents. That’s a real business, not a slide deck, and the numbers are the only thing keeping the polished story from floating away. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1479681/000162828026028849/nutx-20260331.htm)

Behind the scenes, Nutex spent $1.2 million on property, plant, and equipment during the quarter-roughly the cost of a single high-end MRI scanner-while inventory crept up by $1.8 million to $4.7 million. The company’s diluted EPS was $6.52, based on 7.2 million weighted average shares outstanding. The cash is real, the hospital beds are real, and the polished language is real, but the gap between the two is where the story lives. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1479681/000162828026028849/nutx-20260331.htm)

The company’s 8-K filed on 21 July 2026 doesn’t add new financial data but confirms the financials are still ticking over. A 13G/A filing from May 2026 shows a single beneficial owner with over 10% of the float, which is the kind of detail that turns ‘technology-enabled’ into a ‘family office play’ in the minds of investors who prefer substance to spin. (source: 8-K, 2026-07-21, https://www.sec.gov/Archives/edgar/data/1479681/000162828026049061/nutx-20260715.htm; 13G/A, 2026-05-07, https://www.sec.gov/Archives/edgar/data/1479681/000091957426002725/xslSCHEDULE_13G_X02/primary_doc.xml)

For context on the company’s operating model, Nutex Health’s media page describes it as a ‘technology-enabled healthcare services company’ with a Hospital Division and a Population Health Management Division. The Hospital Division operates micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The company’s press releases page is where it posts official announcements, but the filings remain the only source of verifiable financial data. (source: Media - Nutex Health, https://nutexhealth.com/media/; Press Releases - Nutex Health, https://nutexhealth.com/press-releases/)

If you want a rolling view of the company’s filings, the SEC EDGAR index for Nutex Health Inc. (CIK 1479681) is the single best place to start. The index is a firehose of forms, but the 10-Q, 8-K, and 13G/A are the ones that matter for understanding what the company is actually doing versus what it claims to be doing. (source: SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=1479681)

The company’s website and press materials lean heavily on ‘innovation’ and ‘concierge-level care,’ but the only hard numbers we can anchor are the ones from the filings. The 10-Q shows $207.3 million in cash, $515.3 million in liabilities, and $346.3 million in stockholders’ equity at 31 March 2026. The polished story is still polished, but the balance sheet is where the proof lives. (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1479681/000162828026028849/nutx-20260331.htm)

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
NUTX
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

NUTX technical readout

Trend strength (ADX 14)
27.4
Average true range (ATR 14)
9.8081
ATR as % of price
6.58%
Volatility compression (ATR14/ATR50)
1.02x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

NUTX evidence rails

Atlas uses the specific public rails available for NUTX: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on NUTX

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for NUTX Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep NUTX research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

NUTX FAQ

What is Nutex Health Inc. (NUTX)?Nutex Health Inc. (NUTX) has a latest verified close of 162.07, up 6.67%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...

Nutex Health Inc. (NUTX) has a latest verified close of 162.07, up 6.67%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for NUTX?Nutex Health Inc. (NUTX) has a latest verified close of 162.07, up 6.67%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...

Nutex Health Inc. (NUTX) has a latest verified close of 162.07, up 6.67%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files NUTX under USA Stocks and Healthcare & Medicine Stocks for browsing.

How often is the NUTX page updated?The NUTX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The NUTX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for NUTX?The NUTX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:NUTX. SEC EDGAR provides the filing anchor for this issuer. The page separates...

The NUTX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:NUTX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on NUTX?Yes. The workstation can open NUTX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open NUTX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this NUTX page investment advice?No. The NUTX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The NUTX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →